Portfolio News
Sofinnova Crossover & Sofinnova Industrial Biotech
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
Related Company
SynthaceRelated Strategy
CrossoverRelated Strategy
Industrial BiotechRelated Deal lead
Joško BobanovićRelated News
Moon Surgical Expands Maestro® Platform into a Multi-Model Physical AI Platform with Software Version 2.7, Driving Automation Across the Surgical Workflow
Ingenix raises €13M led by Sofinnova to scale Modality Fusion AI
P2 Science raises $23M to expand green chemistry platform
HAYA Therapeutics doses first cohort in Phase 1 trial
Tulyp Medical appoints Steve Motes as CEO